Powered by
Read the full press release here AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved HUMIRA® (adalimumab) for the treatment of moderately to severely active ulcerative colitis in pediatric patients 5 years of age and older.…
Read the full press release here Merck, known as MSD outside the United States and Canada, announced today it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of SARS-CoV-2/COVID-19 medicines and vaccines. The Biomedical…
Read the full press release here Tobias Zutz found himself seeking a new challenge in 2015. With a R&D experience in assay development and molecular diagnostics, he had been a member of the R&D team at Exact Sciences that developed…
Read the full press release here Advocate Aurora Health community cancer clinics are the first sites in Wisconsin to join a new clinical trial studying a treatment for multiple myeloma. The Phase 2 study will evaluate the safety and efficacy…
Gilson enables organizations to scale up COVID-19 testing workflows by Suzanne RestainoDirector of Marketing and Communications, Gilson The development of simple and rapid diagnostic screening tests was critically important in helping control the COVID-19 pandemic. Expanding rapid testing, isolating infected…